Reversibility of Severe Bleomycin-lnduced Pneumonitis
- 12 May 1978
- journal article
- research article
- Published by American Medical Association (AMA)
- Vol. 239 (19) , 2012-2014
- https://doi.org/10.1001/jama.1978.03280460080024
Abstract
The use of bleomycin sulfate as an antineoplastic agent has been limited by its substantial pulmonary toxic effects. The exact incidence and prognosis of bleomycin-pneumonitis is unresolved. Although bleomycin pulmonary toxicity is thought to be dose-related, recent reports have emphasized severe reactions at low doses. Furthermore, severe pulmonary toxicity has been suggested to be progressive, irreversible, and ultimately, fatal. We report clinical, roentgenographic, and pathophysiologic recovery after severe, bleomycin-induced pneumonitis. (JAMA239:2012-2014, 1978)Keywords
This publication has 4 references indexed in Scilit:
- Reversible Interstitial Pneumonitis Associated with Low Dose BleomycinChest, 1975
- A clinical review of bleomycin—a new antineoplastic agentCancer, 1973
- Bleomycin Pulmonary ToxicityChest, 1973
- The Spectrum of Drug-Induced Pulmonary DiseaseAnnals of Internal Medicine, 1972